APA (7th ed.) Citation

Nelson, B. E., Roszik, J., Ahmed, J., Barretto, C. M. N., Nardo, M., Campbell, E., . . . Subbiah, V. (2024). RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: The RE-RAFFLE study. Molecular Cancer, 23(1), 1. https://doi.org/10.1186/s12943-024-01982-4

Chicago Style (17th ed.) Citation

Nelson, Blessie Elizabeth, et al. "RAF Inhibitor Re-challenge Therapy in BRAF-aberrant Pan-cancers: The RE-RAFFLE Study." Molecular Cancer 23, no. 1 (2024): 1. https://doi.org/10.1186/s12943-024-01982-4.

MLA (9th ed.) Citation

Nelson, Blessie Elizabeth, et al. "RAF Inhibitor Re-challenge Therapy in BRAF-aberrant Pan-cancers: The RE-RAFFLE Study." Molecular Cancer, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12943-024-01982-4.